| 2.83 -0.03 (-1.05%) | 04-29 14:03 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term | |
|||
| Targets | 6-month : | 4.49 | 1-year : | 5.37 |
| Resists | First : | 3.85 | Second : | 4.59 |
| Pivot price | 2.99  |
|||
| Supports | First : | 2.64 | Second : | 2.19 |
| MAs | MA(5) : | 2.87 |
MA(20) : | 0 |
| MA(100) : | 0 | MA(250) : | 0 | |
| MACD | MACD : | 0 | Signal : | 0 |
| %K %D | K(14,3) : | 0 | D(3) : | 0 |
| RSI | RSI(14): 23.7 |
|||
| 52-week | High : | 4 | Low : | 2.64 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ ZOOZ ] has closed above bottom band by 5.9%. Bollinger Bands are 0% narrower than normal.
| If tomorrow: | Open lower | Open higher |
| High: | 3 - 3.02 | 3.02 - 3.03 |
| Low: | 2.79 - 2.8 | 2.8 - 2.82 |
| Close: | 2.84 - 2.86 | 2.86 - 2.88 |
Mon, 08 Apr 2024
Why Agenus Shares Are Trading Lower By Around 17%? Here Are Other Stocks Moving In Monday's Mid-Day Session - Investing.com UK
Mon, 08 Apr 2024
Why Agenus Shares Are Trading Lower By Around 17%? Here Are Other Stocks Moving In Monday’s Mid-Day Sessi - Benzinga
Mon, 08 Apr 2024
Why Esperion Therapeutics Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket - A - Benzinga
Fri, 05 Apr 2024
ZOOZ Power Completes Merger with Keyarch Acquisition | DealFlow's SPAC News - DealFlow's SPAC News
Thu, 04 Apr 2024
ZOOZ Power to start trading on Nasdaq with new ticker symbols - Investing.com
Thu, 04 Apr 2024
ZOOZ Power Ltd. Ordinary Shares and Public Warrants to Trade on Nasdaq on April 5, 2024, as the ... - The Bakersfield Californian
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
NASDAQ
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 0 (M) |
| Shares Float | 12 (M) |
| Held by Insiders | 1.48e+006 (%) |
| Held by Institutions | 44.1 (%) |
| Shares Short | 0 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | -4.951e+007 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | -1 % |
| Return on Assets (ttm) | 790 % |
| Return on Equity (ttm) | -45.5 % |
| Qtrly Rev. Growth | 2.81e+006 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | -46 (M) |
| PE Ratio | -0.01 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | 0 |
| Price to Cash Flow | 0 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|